Adropin and inflammation biomarker levels in male patients with obstructive sleep apnea: A link with glucose metabolism and sleep parameters
Journal of Clinical Sleep Medicine Jul 18, 2018
Bozic J, et al. - In patients with moderate and severe obstructive sleep apnea (OSA) vs healthy controls, researchers assessed plasma adropin, systemic inflammation biomarker levels, and glucose metabolism parameters. Participants in the study were 50 male patients with OSA and 25 age- and sex-matched controls. Researchers reported that plasma adropin concentrations are significantly associated with indices of disease severity in patients with OSA. Findings from the present study suggested that adropin potentially plays an important role in the complex pathophysiology of the disease.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries